Literature DB >> 8931213

Models for the incubation of AIDS and variations according to age and period.

A Muñoz1, J Xu.   

Abstract

The objective of the methods proposed is to provide a parametric model for the incubation of AIDS and to use the chosen parameterization to test for the effect of age at seroconversion, and, after adjusting for markers of immunosuppression, to assess variations in periods corresponding to different levels of use of AIDS therapies at the population level. We compared the fit of Weibull, log-normal and three-parameter logistic models incorporating truncation in prevalent cohort and interval censored data. We showed the advantages by restricting the analysis to follow-up durations of greater than five years to improve estimation of the tail of the distribution for the prediction of long-term survivors. We applied the proposed methods to the combination of 1649 seroprevalent and 476 seroconverters with 1022 and 177 AIDS cases, respectively, who have been followed in the Multicenter AIDS Cohort Study (MACS) up to April 1995. Differences according to age at seroconversion are quantified in terms of relative percentiles and their associated 95 per cent confidence intervals were calculated using methods of multiple imputation. Using the proposed methods, we found that the log-normal model provides a fit as good as the three-parameter logistic; both are close to the non-parametric estimate and are significantly better than the fit of the Weibull model. We found that the older the age at seroconversion, the shorter the time to AIDS (relative percentile = 0.72 for age > or = 40 versus age < 25), and that the incubation of AIDS in calendar periods where treatment has been widely administered has been significantly longer among individuals with low CD4 cell counts.

Entities:  

Mesh:

Year:  1996        PMID: 8931213     DOI: 10.1002/(sici)1097-0258(19961130)15:22<2459::aid-sim464>3.0.co;2-q

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Modeling the HIV/AIDS epidemic via survivor functions.

Authors:  G Schinaia
Journal:  Eur J Epidemiol       Date:  2000-06       Impact factor: 8.082

2.  Bayesian posterior distributions without Markov chains.

Authors:  Stephen R Cole; Haitao Chu; Sander Greenland; Ghassan Hamra; David B Richardson
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

3.  Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designs.

Authors:  Francisco J Diaz; Michel J Berg; Ron Krebill; Timothy Welty; Barry E Gidal; Rita Alloway; Michael Privitera
Journal:  Clin Pharmacokinet       Date:  2013-12       Impact factor: 6.447

Review 4.  Can we predict the prognosis of HIV infection? How to use the findings of a prospective study.

Authors:  N Low; M Egger
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

5.  Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.

Authors:  Chanelle J Howe; Stephen R Cole; Joan S Chmiel; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2011-02-02       Impact factor: 4.897

6.  Models for residual time to AIDS.

Authors:  M Shi; J M Taylor; A Muñoz
Journal:  Lifetime Data Anal       Date:  1996       Impact factor: 1.588

7.  Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission.

Authors:  Joshua T Herbeck; Viktor Müller; Brandon S Maust; Bruno Ledergerber; Carlo Torti; Simona Di Giambenedetto; Luuk Gras; Huldrych F Günthard; Lisa P Jacobson; James I Mullins; Geoffrey S Gottlieb
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

8.  Imputation methods for doubly censored HIV data.

Authors:  Wei Zhang; Ying Zhang; Kathryn Chaloner; Jack T Stapleton
Journal:  J Stat Comput Simul       Date:  2009-10-01       Impact factor: 1.424

9.  Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.

Authors:  Shinobu Tatsunami; Junichi Mimaya; Akira Shirahata; Jiří Zelinka; Ivana Horová; Jugo Hanai; Yutaka Nishina; Katsumi Ohira; Masashi Taki
Journal:  Int J Hematol       Date:  2008-08-02       Impact factor: 2.490

10.  Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.

Authors:  Susan L Furth; Stephen R Cole; Marva Moxey-Mims; Frederick Kaskel; Robert Mak; George Schwartz; Craig Wong; Alvaro Muñoz; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2006-07-19       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.